NMDOH details COVID-19 guidance for immunocompromised people
SANTA FE, N.M. – The New Mexico Department of Health announced Wednesday an enhanced set of recommendations for immunocompromised New Mexicans.
The recommendation also applies to transplant recipients and those actively being treated for cancer.
NMDOH describes moderately or severely immunocompromised people as having one or more of these factors:
- They are receiving active chemotherapy or radiation for tumors or blood cancers
- They have received an organ transplant and are taking anti-rejection medication
- They have received a stem cell transplant within the last two years
- They have a primary immunodeficiency syndrome, such as DiGeorge syndrome or Wiskott-Aldrich syndrome
- They have advanced or untreated HIV
- They are taking high dose corticosteroids, such as more than 20 mg of prednisone each day or medicines like methotrexate for rheumatoid arthritis. Some other immune-suppressing medications may qualify.
Individuals should talk to their doctor or call the COVID-19 hotline at 1-855-600-3453, NMDOH says, to determine if their medications qualify them for a fourth dose.